OLABIR 150MG (120) TABLETS
Olaprib Tablets 150 mg
Olabir 150mg (120 Tablets)
Composition: Olaparib 150mg
Therapeutic Class: Anti-Neoplastic (PARP Inhibitor)
Olabir: Globally Proven Anti-Cancer Medicine
Olabir 150mg is a doctor-prescribed targeted therapy anti-cancer medicine containing Olaparib 150mg, available in a 120-tablet pack. It is widely recognized globally for its high efficacy, safety, and affordability.
Aprazer Healthcare: Committed to Affordable Healthcare
Aprazer Healthcare is a leading oncology medicine manufacturer dedicated to developing premium quality anti-cancer formulations. Operating under WHO-GMP certification, Aprazer ensures strict therapeutic quality and safety standards for all pharmaceutical products exported to over 50 countries.
What is Olabir?
Olabir is a Poly (ADP-Ribose) Polymerase (PARP) inhibitor. It is a targeted anti-cancer drug widely used to treat malignancies associated with genetic mutations in BRCA-1 and BRCA-2 genes.
Indications & Uses of Olabir
Olabir 150mg is indicated for:
- Female malignancies – Ovarian Cancer and Breast Cancer
- Pancreatic Cancer
- Prostate Cancer
How Does Olabir Work?
Olabir works by targeting and killing cancer cells through PARP inhibition. It inhibits the DNA-repairing enzyme in tumor cells, preventing faulty gene repair in BRCA-1 and BRCA-2 mutation-bearing cells and inducing cell death.
Common Side Effects
- Tiredness and fatigue
- Low blood counts (anemia, neutropenia)
- Nausea and vomiting
- Breathing difficulty / shortness of breath
- Muscle aches and joint pain
- Dehydration from diarrhea
- Mouth ulcers & heartburn
- Loss of appetite
Serious Side Effects
- Bleeding or blood in urine
- Bone marrow depression
- Lung inflammation (pneumonitis)
- Severe cough, chest pain, and fever
- Acute Myeloid Leukemia (AML) / Myelodysplastic Syndrome (MDS)
Contraindications & Precautions
Do not use Olabir if you have a known hypersensitivity or allergy to Olaparib or any excipients. It is strictly contraindicated in pregnant and breastfeeding women. Cautious use and monitoring are required in patients with pre-existing anemia, kidney or liver impairment, leukemia, or bone marrow suppression history.
Important Monitoring Information
Regular clinical monitoring is mandatory during treatment, including Liver Function Tests (LFT), Complete Blood Count (CBC), Kidney Function Tests (KFT), respiratory function evaluations, and cardiac function checks.
FAQ
Frequently Asked Questions
Why should alcohol be avoided during Olabir (Olaparib) therapy?
Alcohol consumption increases metabolic strain on the liver and can exacerbate drug side effects like dizziness, nausea, and fatigue.
Should painkillers or cough medicines be avoided on Olabir therapy?
Do not take over-the-counter painkillers or cough medications without consulting your oncologist, as unmonitored drug interactions can increase adverse effects or toxicity.
What parameters should be monitored during Olabir therapy?
Complete Blood Count (CBC), Liver Function Tests (LFT), and Kidney Function Tests (KFT) must be routinely monitored throughout treatment.
Does Olabir (Olaparib) cause a metallic taste in the mouth?
Yes, Olaparib can temporarily alter taste perception (dysgeusia), leading to a metallic or unusual taste in the mouth.
Why is driving not recommended while taking Olabir?
Olabir therapy can cause drowsiness, fatigue, and lightheadedness, which may impair driving ability or machine operation safety.
Can Olabir (Olaparib) cause complete hair loss?
Olaparib usually causes hair thinning or changes in hair texture rather than complete hair loss (alopecia).
Why are patients on Olabir more prone to infections?
Olaparib suppresses bone marrow activity and reduces white blood cell counts (neutropenia), lowering the body's infection-fighting capacity.
Why choose Aprazer Healthcare for oncology medicines?
Aprazer Healthcare is a globally recognized WHO-GMP certified pharmaceutical manufacturer providing world-class, affordable oncology products worldwide.
